Combo OTC Drug Labeling Deadlines To Be Addressed In Final Monographs
This article was originally published in The Rose Sheet
Executive Summary
FDA will take into account OTC labeling regulation compliance deadlines when publishing final monographs that could subject combination products to frequent relabeling, the agency says in a June 20 Federal Register notice extending by one year implementation provisions for specific types of OTCs.
You may also be interested in...
OTC Drug Labeling Implementation Date Extended One Year To 2002
FDA is extending the OTC drug labeling implementation date to May 2002 to allow time for the agency to develop "forthcoming guidances" regarding a number of outstanding concerns from trade organizations.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle